BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25495260)

  • 1. Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targets.
    Prakash A; Kalra J; Mani V; Ramasamy K; Majeed AB
    Expert Rev Neurother; 2015 Jan; 15(1):53-71. PubMed ID: 25495260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid clearance as a treatment target against Alzheimer's disease.
    Kurz A; Perneczky R
    J Alzheimers Dis; 2011; 24 Suppl 2():61-73. PubMed ID: 21422524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the therapy of Alzheimer's disease: targeting amyloid beta and tau and perspectives for the future.
    Hampel H; Schneider LS; Giacobini E; Kivipelto M; Sindi S; Dubois B; Broich K; Nisticò R; Aisen PS; Lista S
    Expert Rev Neurother; 2015 Jan; 15(1):83-105. PubMed ID: 25537424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Amyloid as a molecular therapeutic target in Alzheimer's disease.
    Adlard PA; James SA; Bush AI; Masters CL
    Drugs Today (Barc); 2009 Apr; 45(4):293-304. PubMed ID: 19499094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatment for Alzheimer's disease: current approaches and future strategies.
    Fan LY; Chiu MJ
    Acta Neurol Taiwan; 2010 Dec; 19(4):228-45. PubMed ID: 21213151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting nascent soluble Aβ42 for potential Alzheimer drug development.
    Zhang M; Hausmann L; Song W
    J Neurochem; 2013 May; 125(3):329-31. PubMed ID: 23405973
    [No Abstract]   [Full Text] [Related]  

  • 7. Investigational drugs in Alzheimer's disease: current progress.
    Berk C; Paul G; Sabbagh M
    Expert Opin Investig Drugs; 2014 Jun; 23(6):837-46. PubMed ID: 24702504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease.
    Lanari A; Amenta F; Silvestrelli G; Tomassoni D; Parnetti L
    Mech Ageing Dev; 2006 Feb; 127(2):158-65. PubMed ID: 16297434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease: clinical trials and drug development.
    Mangialasche F; Solomon A; Winblad B; Mecocci P; Kivipelto M
    Lancet Neurol; 2010 Jul; 9(7):702-16. PubMed ID: 20610346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel insights for the treatment of Alzheimer's disease.
    Kurz A; Perneczky R
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):373-9. PubMed ID: 20655969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies, development, and pitfalls of therapeutic options for Alzheimer's disease.
    Haas C
    J Alzheimers Dis; 2012; 28(2):241-81. PubMed ID: 21987594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug development in dementia.
    Cunningham EL; Passmore AP
    Maturitas; 2013 Nov; 76(3):260-6. PubMed ID: 23707728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel disease-modifying therapies for Alzheimer's disease.
    Jiang T; Yu JT; Tan L
    J Alzheimers Dis; 2012; 31(3):475-92. PubMed ID: 22669013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medical treatment of Alzheimer's disease].
    López-Pousa S; Serra-Mestres J
    Rev Neurol; 1998 Jun; 26(154):1054-60. PubMed ID: 9658492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The translocator protein as a drug target in Alzheimer's disease.
    Chua SW; Kassiou M; Ittner LM
    Expert Rev Neurother; 2014 Apr; 14(4):439-48. PubMed ID: 24625007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rethinking Alzheimer's disease therapy: are mitochondria the key?
    Ankarcrona M; Mangialasche F; Winblad B
    J Alzheimers Dis; 2010; 20 Suppl 2():S579-90. PubMed ID: 20463405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease 2012: the great amyloid gamble.
    Marchesi VT
    Am J Pathol; 2012 May; 180(5):1762-7. PubMed ID: 22472273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concepts for the treatment of Alzheimer's disease: molecular mechanisms and clinical application.
    Pietrzik C; Behl C
    Int J Exp Pathol; 2005 Jun; 86(3):173-85. PubMed ID: 15910551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurotransmitters in Alzheimer's disease].
    Manzano-Palomo S; De la Morena-Vicente MA; Barquero MS
    Rev Neurol; 2006 Mar 16-31; 42(6):350-3. PubMed ID: 16575771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and emerging therapies for Alzheimer's disease.
    Nygaard HB
    Clin Ther; 2013 Oct; 35(10):1480-9. PubMed ID: 24139420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.